Paediatricians are increasingly children in emergency rooms due to overdosage of cold and cough medicines by parents.

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

The Delhi High Court on Wednesday recorded an undertaking from Sun Pharma that it will not sell its semaglutide formulation — ...

Italian pharmaceutical company Cosmo Pharmaceuticals recently announced that its newly developed male-pattern hair loss treatment achieved significant results in Phase 3 clinical trials. Existing male ...

Pharmacokinetic and safety studies were analyzed to demonstrate the safety and efficacy of TRN-257, as well as previous research on oxybate products.

Southwest Research Institute (SwRI) and Trinity University are developing an intranasal (IN) drug-device combination to treat ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

While many headline-grabbing biologics and advanced therapeutics like cell and gene therapies are approved as injectables, ...

Xeris Biopharma Holdings Inc. (NASDAQ:XERS) is among the hidden multibagger stocks to invest in. On Dec. 1, 2025, XERS ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...